TOSI, M.; CATTERUCCIA, M.; CHERCHI, C.; MIZZONI, I.; D’AMICO, A. Switching therapies: safety profile of Onasemnogene abeparvovec-xioi in a SMA1 patient previously treated with Risdiplam. Acta Myologica, [S. l.], v. 41, n. 3, p. 117–120, 2022. DOI: 10.36185/2532-1900-077. Disponível em: https://www.actamyologica.it/article/view/127. Acesso em: 19 jun. 2024.